InvestorsHub Logo
Followers 897
Posts 149191
Boards Moderated 0
Alias Born 08/13/2010

Re: Drugdoctor post# 21035

Saturday, 10/19/2019 6:32:17 PM

Saturday, October 19, 2019 6:32:17 PM

Post# of 21475
$CVSI CV Sciences’ Pharmaceutical Division is developing synthetically-formulated cannabidiol-based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for treatment of a range of medical conditions.
https://cvsciences.com/about-us/

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.